Long COVID
- Submission status
- Closed
- Submission deadline
Infection with the SARS CoV-2 virus can lead to symptoms that persist for weeks, months, or even years after the acute phase of infection has passed. These symptoms may include fatigue, shortness of breath, difficulty concentrating, loss of taste and smell, heart palpitations, headache, and muscle pain, among others. While estimates vary on the prevalence of long COVID – also known as post-COVID, long-haul COVID, chronic COVID, post-acute COVID-19, and post-acute sequelae COVID-19, or PASC – it is increasingly clear that a substantial proportion of COVID-19 survivors will experience at least one lingering COVID-related symptom. The mechanisms underlying this phenomenon are poorly understood; leading hypotheses include a prolonged inflammatory response, the triggering of autoimmunity, and the presence of viral reservoirs in the body.
This Collection invites research on the causes, risk factors, and frequency of long COVID, as well as on the development of diagnostic tools and treatments.
Editors
-
Nicolas G. Bazan
LSU Health New Orleans, USA
-
Artur Fedorowski
Karolinska University Hospital, Sweden; Karolinska Institute, Sweden
-
Seyed Ehtesham Hasnain
Indian Institute of Technology, India; Sharda University, India
-
Roxana Moslehi
University at Albany - State University of New York, USA
-
Annette Regan
University of San Francisco, USA
This Collection is no longer open for new submissions.
In addition to papers on Long COVID, Scientific Reports welcomes all original research in the field of Immunology. To browse our latest articles in Immunology click here.
